Catalyst Wire Dossier Catalyst Wire Dossier

Drug-eluting beads irinotecan (DEBIRI)

irinotecan-loaded drug-eluting beads
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Drug-eluting beads irinotecan (DEBIRI), covering 2021-05-07 to 2021-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab [Phase 1, Phase 2]

See pricing